A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac
Primary Purpose
Osteoarthritis
Status
Completed
Phase
Phase 3
Locations
Russian Federation
Study Type
Interventional
Intervention
Ketoprofen topical
Diclofenac Topical
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring ketoprofen, diclofenac, osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Patients aged 40-75 years
- Compliance to ACR diagnostic criteria of OA of the knee
- Patients with Kellgren-Lawrence grade 1-3
- Index knee pain should be ≥40 mm on VAS (100mm) scale
Exclusion Criteria:
- Intolerance or allergic reactions to the study therapy
- Usage of NSAIDs within 3 days
- Open skin lesions or dermatological conditions at the site of plaster application
- Surgery or major trauma of the index knee within the previous 12 months
- Pregnant or breast-feeding women
- Alcohol addiction, drug addiction or drug abuse in the past
Sites / Locations
- Maksimum Zdorovya
- City Clinical Hospital #1 n.a. Pirogova
- Rostov State Medical University
- Ryazan State Medical University n.a. I.P.Pavlov
- Saratov State Medical University n.a. V.I.Razumovsky
- Private Healthcare Institution Smolensk Russian Railway Clinical Hospital
- Ulyanovsk Regional Clinical Hospital
- Regional Clinical Hospital
- Clinical Emergency Hospital n.a. N.V.Soloviev
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
ketoprofen
Diclofenac
Arm Description
Outcomes
Primary Outcome Measures
Mean change in walking arthritis pain intensity score
Pain will be assessed by a horizontal 100 mm Visual Analogue Scale (VAS)
Secondary Outcome Measures
Mean change in spontaneous arthritis pain intensity score
Pain will be assessed by a horizontal 100 mm Visual Analogue Scale (VAS)
Knee injury and Osteoarthritis Outcome Score (KOOS)
Mean change in individual parameters and the general normalized Knee injury and Osteoarthritis Outcome Score (KOOS) score (5-point scale)
Global Impression of Improvement (PGI-I)
Patient Global Impression of Improvement (PGI-I) assessment
Adverse events
frequency, severity, relationship with the study drug
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04421911
Brief Title
A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac
Official Title
A Study to Comparing the Efficacy and Safety of the Ketoprofen and Diclofenac in Patients With Osteoarthritis
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
March 20, 2020 (Actual)
Primary Completion Date
September 1, 2020 (Actual)
Study Completion Date
September 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Handok Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Primary objective:
• To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of primary endpoint : Mean change in walking arthritis pain intensity score
Secondary objectives:
To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of secondary endpoints.
To assess safety and tolerability of the Ketoprofen compared with Diclofenac based on the nature and frequency of adverse events in treatment groups
Detailed Description
This trial is designed as an open-label, multicenter, randomized, clinical study for assessment of efficacy and safety of Ketoprofen plaster and Diclofenac plaster in patients with osteoarthritis
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
ketoprofen, diclofenac, osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
236 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ketoprofen
Arm Type
Experimental
Arm Title
Diclofenac
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Ketoprofen topical
Intervention Description
Ketoprofen topical for 21days
Intervention Type
Drug
Intervention Name(s)
Diclofenac Topical
Intervention Description
Diclofenac topical for 21days
Primary Outcome Measure Information:
Title
Mean change in walking arthritis pain intensity score
Description
Pain will be assessed by a horizontal 100 mm Visual Analogue Scale (VAS)
Time Frame
3 weeks
Secondary Outcome Measure Information:
Title
Mean change in spontaneous arthritis pain intensity score
Description
Pain will be assessed by a horizontal 100 mm Visual Analogue Scale (VAS)
Time Frame
3 weeks
Title
Knee injury and Osteoarthritis Outcome Score (KOOS)
Description
Mean change in individual parameters and the general normalized Knee injury and Osteoarthritis Outcome Score (KOOS) score (5-point scale)
Time Frame
3 weeks
Title
Global Impression of Improvement (PGI-I)
Description
Patient Global Impression of Improvement (PGI-I) assessment
Time Frame
3 weeks
Title
Adverse events
Description
frequency, severity, relationship with the study drug
Time Frame
3 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients aged 40-75 years
Compliance to ACR diagnostic criteria of OA of the knee
Patients with Kellgren-Lawrence grade 1-3
Index knee pain should be ≥40 mm on VAS (100mm) scale
Exclusion Criteria:
Intolerance or allergic reactions to the study therapy
Usage of NSAIDs within 3 days
Open skin lesions or dermatological conditions at the site of plaster application
Surgery or major trauma of the index knee within the previous 12 months
Pregnant or breast-feeding women
Alcohol addiction, drug addiction or drug abuse in the past
Facility Information:
Facility Name
Maksimum Zdorovya
City
Kemerovo
Country
Russian Federation
Facility Name
City Clinical Hospital #1 n.a. Pirogova
City
Moscow
Country
Russian Federation
Facility Name
Rostov State Medical University
City
Rostov-on-Don
Country
Russian Federation
Facility Name
Ryazan State Medical University n.a. I.P.Pavlov
City
Ryazan
Country
Russian Federation
Facility Name
Saratov State Medical University n.a. V.I.Razumovsky
City
Saratov
Country
Russian Federation
Facility Name
Private Healthcare Institution Smolensk Russian Railway Clinical Hospital
City
Smolensk
Country
Russian Federation
Facility Name
Ulyanovsk Regional Clinical Hospital
City
Ulyanovsk
Country
Russian Federation
Facility Name
Regional Clinical Hospital
City
Vladimir
Country
Russian Federation
Facility Name
Clinical Emergency Hospital n.a. N.V.Soloviev
City
Yaroslavl
Country
Russian Federation
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac
We'll reach out to this number within 24 hrs